Patient compliance enhancement
ODTx® is orodispersible / dispersible technology free of sugar, useful to improve patient compliance.
Galenix has a great deal of experience in the field of orodispersible/dispersible tablet from lowest to highest strength of active ingredient (0.2 up to 2000mg).
The scalable process, well known in healthcare industries, ensure a good content uniformity whatever the strength.
ODTx® technology is an innovative technology for life cycle management and new chemical entities.
Benefits of ODTx® technology:
GALENIX INNOVATIONS - Allee des Palanques - 33127 ST JEAN D'ILLAC - FRANCE
Tel: +33 (0)826 39 69 18 - Fax: +33 (0)5 56 68 83 01